(Q35581731)

9 August 2017

1 reference

title

Immunotherapy with mycobacteria (English)

1 reference

9 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

31 March 2024

3

Graham A. W. Rook

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14612673

31 March 2024

author name string

Christoph Walker

1

1 reference

9 August 2017

Elzbieta Sawicka

2

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14612673

31 March 2024

publication date

1 December 2003

1 reference

full work available at URL

9 August 2017

https://journals.lww.com/00130832-200312000-00010

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Current Opinion in Allergy and Clinical Immunology

31 March 2024

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

481-486

1 reference

Is immunotherapy effective in allergic disease?

9 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Hay fever, hygiene, and household size

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Advances in childhood asthma: hygiene hypothesis, natural history, and management

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Hygiene hypothesis: fact or fiction?

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Asthma: an epidemic of dysregulated immunity

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Allergy, parasites, and the hygiene hypothesis

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Prevalence of asthma and atopy in two areas of West and East Germany

31 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Siblings, day-care attendance, and the risk of asthma and wheezing during childhood

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease?

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Allergy development and the intestinal microflora during the first year of life

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The influence of infections on the development and severity of allergic disorders

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Hay fever and asthma in relation to markers of infection in the United States

31 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Environmental exposure to endotoxin and its relation to asthma in school-age children

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Transient suppression of atopy in early childhood is associated with high vaccination coverage.

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Mycobacteria and atopy, 6 years later: a fascinating, still unfinished, business

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The inverse association between tuberculin responses and atopic disorder.

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in The Gambia

31 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease

31 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The association between delayed type hypersensitivity reaction to Mycobacterium tuberculosis and atopy in asthmatic children

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy

31 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities

31 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Type 2 Cytokine Gene Activation and Its Relationship to Extent of Disease in Patients with Tuberculosis

31 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Innate immune responses to mycobacteria and the downregulation of atopic responses.

31 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

31 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model.

31 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The effect of bacillus Calmette-Guérin immunization depends on the genetic predisposition to Th2-type responsiveness

31 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae

31 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma

31 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced Th2 responses

31 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice

31 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice

31 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Long-Term Protective and Antigen-Specific Effect of Heat-Killed Mycobacterium vaccae in a Murine Model of Allergic Pulmonary Inflammation

31 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma

31 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The effect of infections on susceptibility to autoimmune and allergic diseases

31 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study

31 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Relation between occurrence of type 1 diabetes and asthma

31 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data.

31 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.

31 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis

31 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells

31 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Control of regulatory T cell development by the transcription factor Foxp3

31 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

31 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

31 March 2024

48

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

31 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

31 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

31 March 2024

51

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Probiotics in the management of atopic eczema

31 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease

31 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma

31 March 2024

54

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma.

31 March 2024

55

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma

31 March 2024

57

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

31 March 2024

58

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

31 March 2024

59

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

31 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production

31 March 2024

61

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

31 March 2024

62

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

31 March 2024

63

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

31 March 2024

64

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

31 March 2024

65

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

The role of Toll-like receptors in immunity against mycobacterial infection

31 March 2024

66

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Expression of CD14 and Toll-like receptor 2 in farmers' and nonfarmers' children

31 March 2024

67

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes

31 March 2024

68

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471

31 March 2024

69

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Susceptibility to mycobacterial infections: the importance of host genetics

31 March 2024

70

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

Influence of the macrophage bacterial resistance gene, Nramp1 (Slc11a1), on the induction of allergic asthma in the mouse

31 March 2024

71

1 reference

https://api.crossref.org/works/10.1097/00130832-200312000-00010

31 March 2024

Identifiers

1 reference

9 August 2017

1 reference